Answer all. The question point wise. Highlight important points

Asking for Preferences
It looks like you may have forgotten to attach your questions or image. Please share them and I'll answer each one point by point with the important highlights!

Exclude the repeated question rest answer everything. 2014 (SN) - Absolutebone conduction test 2013 (SN) - Gelle’s test 2010 (SN) - Absolutebone conduction test 2009 (SN) - Weber’s test 2008 (SN) - Tuning fork test2004 (SN) - PresbyacusisOsteomeatal complex2017 (SN) - Referred Otalgia 2017 (SN) - Preauricalas sinus 2015 (SN) - Preauricalas sinus 2014 (SN) - Keratosis obturans 2013 (SN) - Otomycosis 2012 (SN) - Malignant otitis externa 2011 (SN) - Furunculosis of the ear 2010 (SN) - Keratosis obturans 2009 (SN) - Malignant otitis externa 2008 (SN) - Malignant otitis externa 2007 (SN) - Otomycosis 2007 (SN) - Hematoma au2005 (SN) - Furunculosis of external ear 2004 (SN) - Otomycosis 2003 (SN) - Keratosis obturans 2001 (SN) - Wax ear2011 (SN) - Calorie Test2016 (LQ) - Different stages of ASOM. Treatment of ASOM case with bulging T.M. 2014 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Acute Suppurative Otitis Media. 2010 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Acute Suppurative Otitis Media. 2006 (SN) - Glue ear 2001 (LQ) - Describe the clinical features of Acute Otitis Media in 6 year old child and mention the treatment briefly.2015 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Chronic Suppurative Otitis Media. 2011 (LQ) - Describe the aetiopathogenesis, clinical feature and management of attico-anral type of otitis media. 2004 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Chronic Suppurative Otitis Media.2008 (LQ) - Discuss the complications of CSOM. 2006 (SN) - Bezold’s abscess 2005 (LQ) - Describe the aetiopathology, clinical feature and management of lateral sinus thrombosis 2002 (LQ) - Describe the pathology and complications of unsafe type of Chronic Supportive Otitis Media2016 (LQ) - Different stages of ASOM. Treatment of ASOM case with bulging T.M. 2014 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Acute Suppurative Otitis Media. 2010 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Acute Suppurative Otitis Media. 2006 (SN) - Glue ear 2001 (LQ) - Describe the clinical features of Acute Otitis Media in 6 year old child and mention the treatment briefly.OTOSCLEROSIS 2017 (LQ) - Describe the aetiopathogenesis, clinical feature and management of otosclerosis. 2012 (LQ) - Describe the aetiopathogenesis, clinical feature and management of otosclerosis. 2005 (SN) - Otosclerosis 2003 (LQ) - What is otosclerosis ? Write the clinical feature and management of the disease. 2002 (SN) - Diagnosis of otosclerosis 2001 (SN) - Otosclerosis(SN) - Bell’s palsy 2007 (SN) - Bell’s palsy 2001 (LQ) - Describe the symptoms and signs of Bell’s palsy and mention its treatment briefly.2016 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Meniere’s disease. 2009 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Meniere’s disease. 2007 (LQ) - Describe the aetiopathogenesis, clinical feature and management of Meniere’s disease.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Here are all unique topics answered comprehensively, point by point:

SECTION 1: TUNING FORK TESTS


1. Absolute Bone Conduction (ABC) Test

(2014 SN, 2010 SN)
  • Purpose: Compares the patient's bone conduction (BC) with the examiner's BC to assess sensorineural hearing loss
  • Tuning fork used: 512 Hz
  • Method:
    • All air in the ear canal is excluded (meatus occluded)
    • The vibrating tuning fork is placed on the mastoid of the patient
    • When the patient no longer hears it, it is placed on the examiner's mastoid
    • If the examiner still hears it → ABC reduced → indicates cochlear/SNHL
    • If the examiner does not hear it → ABC normal
  • Significance: Tests cochlear reserve directly
  • Normal result: Patient and examiner hear for equal duration (ABC = normal)
  • Abnormal result (ABC reduced): Sensorineural hearing loss on that side
  • Used as a bedside test to differentiate CHL from SNHL

2. Gelle's Test

(2013 SN)
  • Purpose: Detects fixation of the stapes (as in otosclerosis)
  • Tuning fork used: 512 Hz
  • Method:
    • A Siegle's speculum (air-tight) is placed in the external canal
    • Vibrating tuning fork is placed on the mastoid
    • Air pressure is alternately increased and decreased using the pneumatic speculum
    • Observe for change in loudness
  • Interpretation:
    • Normal (Gelle Positive): Increasing pressure → hearing diminishes; decreasing pressure → hearing improves (normal stapes mobility)
    • Abnormal (Gelle Negative): No change in hearing with pressure changes → stapes is fixed (as in otosclerosis)
  • Key point: A negative Gelle's test is strongly suggestive of otosclerosis

3. Weber's Test

(2009 SN)
  • Purpose: Lateralization test to determine which ear has greater hearing loss
  • Tuning fork: 512 Hz placed on the vertex (midline of forehead or vertex of skull)
  • Interpretation:
    • Conductive Hearing Loss (CHL): Weber lateralizes to the affected (poorer) ear - because the masking noise from environment is eliminated
    • Sensorineural Hearing Loss (SNHL): Weber lateralizes to the better ear
    • Normal / Equal hearing: Sound heard in midline
  • Key mnemonic: "CHL - same side; SNHL - opposite (better) side"
  • Always used with Rinne's test for complete assessment

4. Tuning Fork Tests (General Overview)

(2008 SN)
TestForkPurpose+ve Result-ve Result
Rinne's512 HzAC vs BCAC > BC (normal/SNHL)BC > AC (CHL)
Weber's512 HzLateralizationMidline (normal)Lateralizes (CHL or SNHL)
Schwabach's512 HzBC vs normalEqual (normal)Shortened (SNHL) or prolonged (CHL)
ABC512 HzCochlear reserveEqual (normal)Reduced (SNHL)
Gelle's512 HzStapes mobility+ve = mobile stapes-ve = fixed stapes (otosclerosis)
  • 512 Hz is preferred - gives best results (balance between tactile vibration at low frequency and short duration at high frequency)
  • False negative Rinne: In profound unilateral SNHL, BC > AC via transcranial transmission - test the opposite ear with a Barany noise box (masking)

SECTION 2: PRESBYACUSIS

(2004 SN)
  • Definition: Age-related bilateral progressive sensorineural hearing loss affecting high frequencies first
  • Age group: >60 years; incidence increases with age
  • Pathology (Schuknecht's Classification):
    1. Sensory type - Loss of outer hair cells at basal turn of cochlea; abrupt high frequency loss
    2. Neural type - Loss of spiral ganglion neurons; poor speech discrimination
    3. Strial (metabolic) type - Atrophy of stria vascularis; flat audiogram; best prognosis
    4. Mechanical (Cochlear conductive) type - Stiffening of basilar membrane; gradual slope audiogram
  • Features:
    • Bilateral, symmetrical, gradual high-frequency SNHL
    • Tinnitus (high-pitched)
    • Diplacusis (distorted perception of sound)
    • Phonemic regression - speech discrimination worse than expected from pure tone thresholds
    • Recruitment present
  • Audiogram: Gently sloping downward curve toward high frequencies
  • Management:
    • Hearing aids (most important)
    • Cochlear implant in profound cases
    • Counseling, lip reading
    • No medical cure

SECTION 3: OSTEOMEATAL COMPLEX (OMC)

(2004 SN)
  • Definition: A functional unit in the lateral nasal wall in the middle meatus through which drainage of anterior group of sinuses occurs
  • Components:
    • Uncinate process
    • Ethmoidal bulla
    • Hiatus semilunaris
    • Infundibulum
    • Ostia of maxillary, anterior ethmoid, and frontal sinuses
  • Importance:
    • Any obstruction here (polyps, mucosal edema, anatomical variants) leads to recurrent sinusitis
    • Anatomical variants causing OMC obstruction: concha bullosa, paradoxical middle turbinate, Haller cell, deviated septum
  • Clinical significance: Target of FESS (Functional Endoscopic Sinus Surgery)
    • FESS restores drainage via the OMC without disturbing normal mucosa

SECTION 4: REFERRED OTALGIA

(2017 SN)
  • Definition: Ear pain arising from distant sites due to shared nerve supply - the ear itself is normal
  • Nerve supply of ear (sensory):
    • Auriculotemporal nerve (V3) - TMJ, lower teeth
    • Facial nerve (VII) - Geniculate ganglion
    • Glossopharyngeal (IX) - Tonsil, pharynx, tongue base
    • Vagus (X) - Larynx, hypopharynx, esophagus
    • Greater auricular nerve (C2, C3) - Cervical spine
  • Common causes by nerve:
NerveSource of Referred Pain
V3TMJ disorders, impacted 3rd molar, dental caries
VIIGeniculate herpes (Ramsay Hunt)
IXTonsillitis, peritonsillar abscess, carcinoma tonsil/tongue base
XCarcinoma larynx, hypopharynx, esophageal disease
C2/C3Cervical spondylosis
  • Key point: Always examine throat, teeth, cervical spine when no local ear cause is found
  • Most important cause to exclude: Malignancy of pharynx/larynx

SECTION 5: PREAURICULAR SINUS

(2017 SN, 2015 SN)
  • Definition: A congenital pit/sinus anterior to the tragus and helix of the ear
  • Embryology: Failure of fusion of the 6 hillocks of His (during development of the pinna in 6th week of fetal life)
  • Location: Usually at the anterior margin of the ascending helix
  • Lined by: Stratified squamous epithelium; contains desquamating material
  • Inheritance: Autosomal dominant; bilateral in 25-50%
  • Clinical features:
    • Usually asymptomatic
    • Intermittent discharge of whitish cheesy material
    • Recurrent abscess formation when infected
    • Tender swelling, redness, pain on infection
  • Complications: Recurrent infection, abscess, fistula formation
  • Management:
    • Asymptomatic: Observe
    • Infected: Antibiotics first, drain abscess if fluctuant
    • Definitive: Complete surgical excision of the entire sinus tract (recurrence if incomplete)
    • Must trace the entire sinus tract to the perichondrium

SECTION 6: KERATOSIS OBTURANS

(2014 SN, 2010 SN, 2003 SN)
  • Definition: Accumulation of desquamated keratin plugs in the EAC (bony part), leading to widening and erosion of the canal
  • Etiology: Defective epithelial migration in the EAC; associated with sinusitis and bronchiectasis
  • Pathology: Plug of keratin fills entire EAC; canal wall becomes smooth and widened
  • Features:
    • Severe otalgia (main symptom)
    • Conductive hearing loss
    • Profuse foul-smelling discharge
    • Bilateral (50%)
    • Younger age group
    • Canal is widened and smooth on otoscopy
  • Differentiate from EAC cholesteatoma:
FeatureKeratosis ObturansEAC Cholesteatoma
LocationCanal (diffuse)Posterior wall focus
PainSevereMild/dull
CanalWidened, smoothBone erosion, sequestrum
AgeYoungElderly
BilateralCommonRare
AssociationSinusitis, bronchiectasisNone specific
  • Management: Removal of keratin plug under GA + regular suction clearance; NOT surgery unless complications

SECTION 7: OTOMYCOSIS

(2013 SN, 2007 SN, 2004 SN)
  • Definition: Fungal infection of the external auditory canal
  • Organisms:
    • Aspergillus niger (black spores - most common overall)
    • Aspergillus fumigatus (greenish)
    • Candida albicans (white, creamy)
  • Predisposing factors: Humid climate, use of broad-spectrum antibiotics, immunosuppression, diabetes, swimming, topical steroids
  • Features:
    • Intense pruritus (main complaint)
    • Mild to moderate hearing loss
    • Scanty discharge
    • Characteristic appearance: Black or greenish spore-bearing hyphae visible like "wet blotting paper" or fungal mat
    • Aspergillus: Black dots (conidia) on white or yellow background
    • Candida: White creamy discharge
  • Diagnosis: Clinical + microscopy + culture
  • Management:
    • Thorough aural toilet (suction cleaning)
    • Antifungal drops: Clotrimazole 1% solution (first choice), or nystatin
    • Boric acid in spirit (3%) - acidifies canal, inhibits fungal growth
    • Systemic antifungals (itraconazole) if severe/immunocompromised
    • Keep ear dry

SECTION 8: MALIGNANT (NECROTIZING) OTITIS EXTERNA

(2012 SN, 2009 SN, 2008 SN)
  • Definition: An aggressive, life-threatening infection of the EAC spreading to the skull base
  • Causative organism: Pseudomonas aeruginosa (>95% cases)
  • Predisposing factors:
    • Diabetes mellitus (most common - elderly diabetics)
    • Immunocompromised (HIV, chemotherapy, steroids)
    • Elderly patients
  • Pathogenesis: Pseudomonas invades EAC → through fissures of Santorini → osteomyelitis of temporal bone → spreads to skull base
  • Clinical features:
    • Severe, unrelenting otalgia (disproportionate to examination findings)
    • Purulent otorrhoea
    • Granulation tissue at bony-cartilaginous junction (pathognomonic)
    • Facial nerve palsy (most common cranial nerve involved - VII)
    • Progressive involvement: IX, X, XI (jugular foramen syndrome)
    • Low-grade fever
    • No response to conventional treatment
  • Investigations:
    • ESR elevated
    • Gallium-67 scan - most sensitive for activity/monitoring
    • Technetium-99 bone scan - shows early bone involvement
    • CT scan - shows bone erosion, extent of disease
    • MRI - soft tissue extension
    • Culture: Pseudomonas aeruginosa
  • Management:
    • Long-term anti-pseudomonal antibiotics (6-8 weeks minimum):
      • Ciprofloxacin (oral, high dose) - drug of choice
      • IV Piperacillin-tazobactam or ceftazidime for severe cases
    • Aural toilet and debridement
    • Strict diabetic control
    • Hyperbaric oxygen therapy (adjunct)
    • Surgery: limited role - only if medical treatment fails
  • Mortality: High if untreated; cranial nerve involvement worsens prognosis

SECTION 9: FURUNCULOSIS OF THE EAR

(2011 SN, 2005 SN)
  • Definition: Acute staphylococcal infection of a hair follicle in the cartilaginous (outer 1/3) EAC
  • Organism: Staphylococcus aureus
  • Note: Only cartilaginous EAC has hair follicles; bony EAC does NOT, so furuncle is limited to the outer third
  • Clinical features:
    • Severe, throbbing otalgia - worse on chewing (TMJ movement), opening mouth, tragal pressure
    • Trismus (if severe)
    • Pain on pulling the pinna (differentiates from otitis media)
    • Narrowing/occlusion of EAC → conductive hearing loss
    • Regional lymphadenopathy (pre/post-auricular)
    • Systemically, not very toxic (unlike malignant OE)
  • Otoscopy: Localized red swelling in outer EAC, single/multiple
  • Management:
    • Conservative (early): Oral antibiotics (flucloxacillin/amoxiclav), NSAIDS, local heat
    • Incision and drainage once fluctuant (under LA)
    • Ribbon gauze soaked in 10% ichthyol glycerine in canal
    • Swab for culture and sensitivity
    • Treat underlying conditions (diabetes, eczema)

SECTION 10: HEMATOMA AURIS

(2007 SN)
  • Definition: Collection of blood between the perichondrium and auricular cartilage
  • Cause: Direct blunt trauma to the pinna (common in wrestlers, rugby players - "Cauliflower ear")
  • Pathology: Blood separates perichondrium from cartilage → cartilage loses blood supply → fibrosis and calcification
  • Clinical features:
    • Smooth, fluctuant, painless swelling on the anterior surface of the pinna
    • Purple/bluish discoloration
    • Loss of normal auricular contours
  • Complications: If untreated → organization → fibrosis → cauliflower ear (perichondritis, cartilage necrosis)
  • Management:
    • Aspiration (early, within 24-48 hours) under strict asepsis
    • Incision and drainage if large/clotted
    • Pressure bandage (through-and-through sutures or bolster dressing) to prevent re-accumulation
    • Antibiotics to prevent perichondritis
    • Repeat aspiration if recurs; surgical drainage for organized hematoma

SECTION 11: WAX (CERUMEN) IN EAR

(2001 SN)
  • Definition: Accumulation of cerumen (wax) in the EAC causing symptoms
  • Composition: Secretions of ceruminous glands + sebaceous glands + desquamated epithelium
  • Types: Hard (dry), soft (wet), obstructive
  • Clinical features:
    • Conductive hearing loss (sudden, often after bathing - wax swells)
    • Tinnitus, sense of fullness
    • Reflex cough (Arnold's reflex - vagal branch in EAC)
    • Otalgia (if impacted)
  • Indications for removal: Symptomatic, impairs otoscopy, before audiometry
  • Removal methods:
    1. Syringing (most common) - warm water at body temperature, directed at posterior wall; contraindicated if TM perforation, history of ear surgery, CSOM
    2. Aural toilet - using Jobson Horne probe with cotton wool
    3. Softening agents first - sodium bicarbonate drops, olive oil, cerumenolytic agents (3-5 days before syringing)
    4. Microsuction (safest method, used in perforated TM)

SECTION 12: CALORIE TEST

(2011 SN)
  • Definition: A test of vestibular function (horizontal semicircular canal and superior vestibular nerve)
  • Principle: Thermal stimulation creates convection currents in the endolymph of the horizontal semicircular canal, generating nystagmus
  • Procedure (Fitzgerald-Hallpike method):
    • Patient lies supine, head elevated 30° (brings horizontal SCC into vertical plane)
    • Irrigate each ear with:
      • Cold water (30°C) - COWS mnemonic: Cold Opposite
      • Warm water (44°C) - Warm Same side
    • Duration: 40 seconds; wait 5 minutes between tests
    • Normal: Nystagmus for 90-120 seconds
    • Canal paresis: Reduced/absent response on that side
    • Directional preponderance: Nystagmus greater in one direction
  • Mnemonic: COWS - Cold Opposite, Warm Same (direction of fast phase of nystagmus)
  • Clinical uses:
    • Assess vestibular function
    • Diagnose unilateral vestibular hypofunction
    • Evaluate Meniere's disease (reduced caloric response in affected ear)
    • Pre-cochlear implant assessment

SECTION 13: GLUE EAR (Secretory Otitis Media / Otitis Media with Effusion)

(2006 SN)
  • Definition: Accumulation of thick, viscous, mucoid fluid in the middle ear cleft without signs of acute inflammation
  • Most common cause of CHL in children (peak age 2-5 years)
  • Etiopathogenesis:
    • Eustachian tube dysfunction (most important)
    • Adenoid hypertrophy blocking ET orifice
    • Recurrent AOM, allergy, cleft palate
    • Impaired mucociliary clearance
    • Fluid becomes thick ("glue-like") due to goblet cell hyperplasia
  • Clinical features:
    • Bilateral conductive hearing loss (20-40 dB)
    • Dull, retracted, amber or blue TM
    • Air-fluid level or bubbles behind TM
    • No pain (unlike ASOM)
    • Speech delay, inattention, poor school performance
  • Investigations:
    • Tympanometry: Type B (flat) curve - most diagnostic
    • Audiometry: CHL
    • Otoscopy: dull, retracted TM
  • Management:
    • Watchful waiting (3 months) - 50% resolve spontaneously
    • Autoinflation (Valsalva, Otovent balloon)
    • Treat adenoids
    • Grommets (ventilation tubes) - if persists >3 months with hearing loss ≥25 dB; restores hearing immediately
    • Adenoidectomy + grommet insertion (children >4 years)
    • Hearing aids if surgery not possible

SECTION 14: ACUTE SUPPURATIVE OTITIS MEDIA (ASOM)

(2016 LQ, 2014 LQ, 2010 LQ, 2001 LQ)

A. Stages of ASOM

StageFeaturesTM Appearance
1. Eustachian tube occlusionNegative pressure, retraction of TMRetracted, dull
2. Hyperemia (Pre-suppuration)Congestion, otalgia beginsCongested, pink
3. Suppuration (Exudation)Pus in middle ear, bulging TM, severe painBulging, red, loss of landmarks
4. Coalescence (Pre-perforation)TM about to rupture, severe pain, feverBulging with yellow spot
5. ResolutionTM perforates → pain and fever subsidePerforation, then heals
6. ComplicationIf TM doesn't perforate or infection spreadsMastoiditis, meningitis

B. Aetiopathogenesis

  • Age: Most common in children 6 months - 2 years (horizontal ET, large adenoids)
  • Route: Ascending infection via Eustachian tube (most common)
  • Organisms:
    • Streptococcus pneumoniae (most common)
    • Haemophilus influenzae (2nd most common, especially non-typeable)
    • Moraxella catarrhalis
    • Staphylococcus aureus (post-perforation)
    • Group A Streptococcus
  • Predisposing factors: URTI, adenoid hypertrophy, cleft palate, immunodeficiency, day care, bottle feeding

C. Clinical Features

  • Otalgia - severe, throbbing, often wakes child at night
  • Fever (high grade)
  • Hearing loss (conductive)
  • Otorrhea (mucopurulent) - once TM perforates, pain suddenly relieves
  • In infants: ear tugging, irritability, poor feeding, vomiting
  • Otoscopy: TM red, congested, bulging, loss of landmarks and light reflex

D. Management

Bulging TM (Stage 3-4): Active management required

  • Analgesia: Paracetamol + ibuprofen
  • Antibiotics (drug of choice): Amoxicillin (high dose: 80-90 mg/kg/day in 2-3 divided doses x 10 days)
    • Penicillin allergic: Azithromycin or Cefuroxime
    • Resistant cases: Amoxicillin-clavulanate
  • Nasal decongestants: Xylometazoline drops (helps ET function)
  • Myringotomy (paracetesis): Incision of TM
    • Indications: Bulging TM with severe pain, no response to antibiotics in 48 hrs, suppurative complications, immunocompromised, age < 6 months
    • Site: Anteroinferior quadrant of TM
  • Follow-up at 6-8 weeks to ensure resolution

SECTION 15: CHRONIC SUPPURATIVE OTITIS MEDIA (CSOM)

A. General (2015 LQ, 2004 LQ)

  • Definition: Chronic inflammation of the middle ear and mastoid with persistent TM perforation and discharge for >6-12 weeks
  • Two types:
    1. Tubotympanic (Safe/Benign) - central perforation, no cholesteatoma
    2. Atticoantral (Unsafe/Dangerous) - marginal/attic perforation, cholesteatoma

B. Tubotympanic (Safe) CSOM

FeatureDetail
PerforationCentral (pars tensa)
DischargeMucoid/mucopurulent, intermittent, not foul-smelling
CholesteatomaAbsent
ComplicationsRare
Hearing lossMild to moderate CHL
  • Organisms: Pseudomonas aeruginosa, Staphylococcus aureus, Proteus, E.coli
  • Management:
    • Aural toilet (dry mopping/suction)
    • Topical antibiotics: Ciprofloxacin ear drops (drug of choice); avoid aminoglycosides if TM perforated
    • Treat upper respiratory infection
    • Myringoplasty (repair TM) once ear is dry for 3 months
    • Tympanoplasty if ossicular involvement

C. Atticoantral (Unsafe) CSOM / Cholesteatoma

(2011 LQ - Atticoantral type)
  • Key feature: CHOLESTEATOMA (keratinizing squamous epithelium in middle ear)
  • Types of cholesteatoma:
    • Congenital (behind intact TM)
    • Acquired - Primary (pars flaccida retraction) or Secondary (epithelial invasion through marginal perforation)
  • Perforation: Attic (Shrapnell's membrane) or posterior marginal
  • Discharge: Scanty, foul-smelling (offensive odor due to bone erosion + infection)
  • Features:
    • "No pain, no gain" is false here - painless until complications
    • Granulation tissue, polyp
    • Bony erosion of ossicles, tegmen, lateral sinus plate, facial canal
    • Hearing loss - CHL or mixed
  • Investigations: HRCT temporal bone (shows soft tissue density, bone erosion)
  • Management: SURGERY is mandatory (no conservative cure)
    • Atticotomy (limited disease)
    • Modified radical mastoidectomy (extensive disease)
    • Canal wall up (CWU) or Canal wall down (CWD) mastoidectomy

SECTION 16: COMPLICATIONS OF CSOM

(2008 LQ)

Extracranial Complications

ComplicationNotes
MastoiditisMost common; pain, swelling, tenderness over mastoid
Subperiosteal abscessPinna displaced forward and downward
Bezold's abscessPus tracks through tip of mastoid → neck
Citelli's abscessPus tracks to digastric triangle
Luc's abscessPus under temporalis muscle
PetrositisGradenigo's triad: discharging ear + lateral rectus palsy (VI) + retro-orbital pain
LabyrinthitisVertigo, SNHL
Facial nerve palsyVia facial canal erosion

Intracranial Complications

ComplicationNotes
Extradural abscessMost common IC complication
Subdural abscessHigh mortality; rapidly progressing
MeningitisMost common fatal IC complication
Brain abscessTemporal lobe (CSOM) or cerebellar (mastoiditis)
Lateral (sigmoid) sinus thrombosisPicket-fence fever, Griesinger's sign
Otitic hydrocephalusRaised ICP without brain abscess

Bezold's Abscess

(2006 SN)
  • Definition: Abscess formed when pus from mastoiditis perforates the medial surface of the mastoid tip (inner cortex) and tracks along the sternocleidomastoid muscle
  • Pathogenesis: Mastoid empyema → erosion of thin medial cortex of mastoid tip → pus under SCM → neck abscess
  • Features:
    • Deep, tender neck swelling along the anterior border of SCM
    • Ear discharge, otalgia, fever
    • Head tilted toward affected side
    • Trismus if pterygoids involved
  • Differentiate from Citelli's abscess: Bezold = along SCM; Citelli = posterior belly of digastric
  • Management: Drainage + mastoidectomy + antibiotics

SECTION 17: LATERAL SINUS THROMBOSIS

(2005 LQ)
  • Alternate name: Sigmoid sinus thrombophlebitis
  • Pathogenesis: CSOM/cholesteatoma → erosion of bony plate over lateral (sigmoid) sinus → perisinus abscess → thrombophlebitis → thrombosis
  • Clinical features:
    • "Picket-fence" (quotidian) spiking fever - classic
    • Rigors and sweating
    • Griesinger's sign - edema over mastoid emissary vein (pathognomonic)
    • Tobey-Ayer test - compression of ipsilateral IJV does NOT raise CSF pressure (due to thrombus)
    • Crowe-Beck test - compression of contralateral IJV raises CSF pressure normally
    • Headache, septicemia
    • Papilledema (raised ICP)
    • Septic emboli → septic pulmonary infarcts, meningitis
  • Investigations:
    • MRI/MRV - gold standard (shows "empty delta sign" on MRI with contrast if superior sagittal sinus involved)
    • CT with contrast
    • Blood culture (positive for causative organism)
  • Management:
    • Mastoidectomy to remove source
    • Antibiotics (IV, broad-spectrum - target Pseudomonas, Staph, anaerobes)
    • Anticoagulation (controversial but used in progressive cases)
    • Ligation of IJV (if septic emboli persist despite treatment)
    • Surgical drainage of perisinus abscess

SECTION 18: OTOSCLEROSIS

(2017 LQ, 2012 LQ, 2005 SN, 2003 LQ, 2002 SN, 2001 SN)

A. Aetiopathogenesis

  • Definition: Disorder of enchondral bone of otic capsule characterized by localized areas of abnormal bone remodeling
  • Genetics: Autosomal dominant with 25-40% penetrance; family history in 25% cases
  • Sex: Female > Male (2:1); worsens during pregnancy
  • Age: 15-45 years (reproductive age group)
  • Bilateral in 70-80% of cases
  • Pathology:
    • Most common focus: Fissula ante fenestram (anterior to oval window)
    • Abnormal bone (otospongiosis) replaces normal endochondral bone → stapes footplate fixed
    • Result: Progressive conductive hearing loss
    • If spreads to cochlea (cochlear otosclerosis) → mixed or SNHL
  • Possible triggers: Measles virus (controversial), fluoride, estrogen

B. Clinical Features

  • Progressive bilateral CHL (usually starts in one ear)
  • Age of onset: 2nd-3rd decade
  • Paracusis Willisii: Hears better in noisy environments (because others raise voice - stapes fixation prevents transmission of low-frequency background noise)
  • Tinnitus (low frequency)
  • Family history positive
  • Flamingo pink (Schwartze sign): Pinkish glow through TM due to increased vascularity of active otospongiosis (seen in early active disease)

C. Investigations

  • Pure tone audiometry:
    • Carhart's notch at 2000 Hz (dip in BC at 2 kHz - a mechanical effect of stapes fixation, NOT true SNHL)
    • CHL with bone conduction better than air conduction
  • Tympanometry: Type As (stiffness type - reduced compliance, normal peak pressure)
  • Gelle's test: NEGATIVE (fixed stapes)
  • Stapedial reflex: ABSENT
  • HRCT temporal bone: Halo sign (radiolucency around cochlea - "double ring sign")

D. Management

Medical (limited role):

  • Sodium fluoride - retards progression; converts active spongiotic bone to stable sclerotic bone (250-500 mg/day)
  • Bisphosphonates - emerging evidence
  • Calcium and Vitamin D

Surgical (treatment of choice):

  • Stapedectomy / Stapedotomy (standard treatment)
    • Stapedotomy is preferred (small hole in footplate, piston prosthesis)
    • Prosthesis: Teflon, stainless steel, titanium
    • Success rate: >90% - postoperative BC thresholds improve (Carhart's notch disappears)
    • Complication: Perilymph fistula, SNHL (dead ear - 1%), tinnitus, taste disturbance (chorda tympani)
  • Hearing aid - alternative if surgery refused or not feasible

SECTION 19: BELL'S PALSY

(2007 SN, 2001 LQ)

A. Symptoms and Signs

  • Definition: Acute idiopathic unilateral lower motor neurone (LMN) facial nerve palsy - diagnosis of exclusion
  • Cause: Believed to be reactivation of Herpes simplex virus type 1 causing inflammation and edema of facial nerve within the Fallopian canal

Symptoms:

  • Sudden onset unilateral facial weakness (over hours to days)
  • Inability to close eye (lagophthalmos) - most dangerous symptom
  • Drooping of corner of mouth
  • Drooling of saliva
  • Difficulty chewing, whistling
  • Hyperacusis (if nerve to stapedius involved)
  • Loss of taste (anterior 2/3 tongue) - chorda tympani involvement
  • Decreased lacrimation/salivation - if proximal to geniculate ganglion
  • Post-auricular pain (often precedes palsy by 24-48 hrs)

Signs:

  • Unilateral LMN facial palsy (all branches affected - forehead spared in UMN)
  • Inability to raise eyebrow, close eye, puff cheek, smile
  • Bell's phenomenon: Eyeball rolls upward on attempting to close eye (protective reflex - positive = intact CN III)
  • Nasolabial fold flattened
  • Loss of corneal reflex (ophthalmic branch via VII efferent)
  • Grading: House-Brackmann scale (I = normal, VI = complete paralysis)

B. Investigations

  • Nerve conduction studies (Electroneuronography - ENoG)
  • Audiometry
  • MRI with gadolinium (if atypical or no recovery)
  • Blood sugar, serology for HSV/VZV

C. Treatment

  1. Eye care (most important):
    • Artificial tears (lubricant eye drops) during day
    • Eye ointment + taping eye shut at night
    • Protective glasses
  2. Corticosteroids (first-line):
    • Prednisolone 1 mg/kg/day (maximum 60 mg) for 10 days, started within 72 hours
    • Improves recovery rate significantly
  3. Antiviral (controversial but used):
    • Acyclovir or Valacyclovir + steroids (mainly for severe/complete palsy)
  4. Physiotherapy: Facial muscle exercises
  5. Surgery: Facial nerve decompression (controversial, rarely done now)
  • Prognosis: 85% recover completely within 3-6 months; incomplete palsy has better prognosis

SECTION 20: MENIERE'S DISEASE

(2016 LQ, 2009 LQ, 2007 LQ)

A. Aetiopathogenesis

  • Definition: Idiopathic condition characterized by endolymphatic hydrops (increased endolymph volume/pressure in the membranous labyrinth)
  • Pathology:
    • Impaired endolymph absorption (possibly due to endolymphatic sac dysfunction)
    • Endolymph accumulates → distension of scala media and saccule
    • Eventually: Reissner's membrane ruptures → endolymph mixes with perilymph → acute attack of vertigo
  • Possible causes:
    • Autoimmune (strong evidence)
    • Allergy
    • Viral infection
    • Vascular insufficiency
    • Anatomical abnormality (narrow endolymphatic duct/sac)

B. Clinical Features - Classic Triad

"ELV" - Episodic Vertigo + Low-frequency hearing Loss + Tinnitus
  1. Episodic vertigo:
    • Sudden, severe, rotatory, lasting 20 minutes to 24 hours
    • Accompanied by nausea and vomiting
    • NOT triggered by head movement (unlike BPPV)
    • Patient is incapacitated during attack
  2. Fluctuating SNHL:
    • Low-frequency loss initially (distinguishes from other SNHL)
    • Fluctuates - worse during attacks, improves between attacks
    • Progressive with repeated attacks
  3. Tinnitus:
    • Low-pitched, roaring/sea-shell quality
    • Increases before/during attacks
  4. Aural fullness/pressure (4th feature - ear congestion)
  • Unilateral in 85% of cases
  • Lermoyez syndrome: Variant where tinnitus + hearing loss precede vertigo, and vertigo relieves them

C. Investigations

  • Audiometry: Low-frequency SNHL; type B or C tympanogram (normal in early stages; flat curve in end-stage)
  • Electrocochleography (ECoG): SP:AP ratio > 0.3-0.4 (summating potential to action potential ratio elevated) - most specific
  • Glycerol dehydration test (Glycerol test): Oral glycerol improves hearing by 15 dB = positive → supports diagnosis
  • Caloric test: Reduced or absent response on affected side (canal paresis)
  • Furosemide test: Similar principle to glycerol test
  • MRI: To exclude acoustic neuroma

D. Management

Acute Attack:

  • Bed rest in a quiet, dark room
  • Prochlorperazine (vestibular sedative) IM/oral
  • Dimenhydrinate (antihistamine/antiemetic)
  • IV fluids if vomiting

Prophylactic (Between attacks):

  • Low-salt diet (<1.5 g Na/day) + fluid restriction - most important lifestyle measure
  • Betahistine (16 mg TDS) - improves labyrinthine microcirculation; reduces attack frequency
  • Diuretics: Hydrochlorothiazide + triamterene (reduces endolymph production)
  • Stress management, avoid caffeine, alcohol, nicotine

Surgical/Interventional (refractory cases):

  • Intratympanic gentamicin injection - chemical labyrinthectomy (destroys vestibular function; risk to hearing)
  • Intratympanic steroids (dexamethasone) - controls vertigo, preserves hearing
  • Endolymphatic sac decompression/shunt - drains excess endolymph (controversial efficacy)
  • Vestibular nerve section - definitive for vertigo, preserves hearing
  • Labyrinthectomy - if no useful hearing; complete cure of vertigo

Source references: Cummings Otolaryngology Head and Neck Surgery; Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol 2; K.J. Lee's Essential Otolaryngology
This is a shared conversation. Sign in to Orris to start your own chat.